New York A 5914: Designates Xylazine as a schedule III depressant

Status: REFERRED TO HEALTH (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: A 5914

Sponsors: Carrie Woerner

View New York A 5914 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.